Literature DB >> 28849049

The protective effect of berberine hydrochloride on LPS‑induced osteoclastogenesis through inhibiting TRAF6‑Ca2+‑calcineurin‑NFATcl signaling pathway.

Fei Ye1, Qingzhong Zhou1, Long Tian1, Fei Lei1, Daxiong Feng1.   

Abstract

The present study investigated the protective effect of berberine hydrochloride on lipopolysaccharide (LPS) ‑induced acute bone destruction through inhibition of the TNF receptor associated factor 6 (TRAF6)‑Ca2+‑calcineurin‑nuclear factor of activated T‑cell 1 (NFATc1) signaling pathway. An osteoclast culture system of RAW264.7 cells induced by LPS in vitro was established. A polymerase chain reaction (PCR) assay was applied to determine the effect of berberine hydrochloride on the mRNA expression levels of fos‑related antigen 2 (Fra‑2), tartrate‑resistant acid phosphatase (TRAP), β3‑integrin, cathepsin K, dendritic cell‑specific transmembrane protein (DC‑STAMP), V‑type proton ATPase subunit d 2 (Atp6v0d2) and NFATcl. An ELISA assay was performed to measure the release of tumor necrosis factor‑α (TNF‑α). Western blot analysis was used to measure the effect of berberine hydrochloride on the expression of calcineurin in the LPS‑induced NFATc1 signaling pathway, as well as the expression levels of phosphoinositide phospholipase C‑γl (PLC‑γ1), toll like receptor 4 (TLR4) and TRAF6. The effect of berberine hydrochloride on Ca2+ concentration was detected using a confocal technique with a Flou‑3/acetoxymethyl ester Ca2+ probe. The PCR results demonstrated that berberine hydrochloride inhibited the mRNA expression levels of Fra‑2, TRAP, β3‑integrin, cathepsin K, DC‑STAMP, Atp6v0d2 and NFATc1. Furthermore, the ELISA results demonstrated that TNF‑α expression was decreased. The western blot analysis revelead that berberine hydrochloride treatment results in decreased expression levels of PLC‑γ1, TLR4 and TRAF6, and inhibition of Ca2+ influx. In conclusion, the results of the present study suggest that berberine hydrochloride targets TRAF6 and NFATc1, thus inhibiting osteoclastogenesis and bone destruction via inhibition of the TRAF6Ca2+‑calcineurin‑NFATcl signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28849049     DOI: 10.3892/mmr.2017.7338

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  8 in total

1.  Inhibition of berberine hydrochloride on Candida albicans biofilm formation.

Authors:  Xiaoxue Huang; Mingyue Zheng; Yuling Yi; Anamica Patel; Zhen Song; Yan Li
Journal:  Biotechnol Lett       Date:  2020-06-15       Impact factor: 2.461

2.  Berberine attenuates non-alcoholic steatohepatitis by regulating chemerin/CMKLR1 signalling pathway and Treg/Th17 ratio.

Authors:  Zengsheng Lu; Fengbin Lu; Liyan Wu; Beihui He; Zhiyun Chen; Maoxiang Yan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-06-10       Impact factor: 3.000

Review 3.  The Role of Ca2+-NFATc1 Signaling and Its Modulation on Osteoclastogenesis.

Authors:  Jung Yun Kang; Namju Kang; Yu-Mi Yang; Jeong Hee Hong; Dong Min Shin
Journal:  Int J Mol Sci       Date:  2020-05-21       Impact factor: 5.923

Review 4.  Overview of RAW264.7 for osteoclastogensis study: Phenotype and stimuli.

Authors:  Lingbo Kong; Wanli Smith; Dingjun Hao
Journal:  J Cell Mol Med       Date:  2019-03-20       Impact factor: 5.310

5.  Network Pharmacological Study of Achyranthis bidentatae Radix Effect on Bone Trauma.

Authors:  Liying Wu; Youguo Hao; Chuanqiang Dai; Zhibang Zhang; Munazza Ijaz; Sobhy M Ibrahim; Ghulam Murtaza; Zhiguang Yao
Journal:  Biomed Res Int       Date:  2021-03-06       Impact factor: 3.411

Review 6.  Berberine as a potential agent for breast cancer therapy.

Authors:  Xiao-Dan Zhong; Li-Juan Chen; Xin-Yang Xu; Yan-Jun Liu; Fan Tao; Ming-Hui Zhu; Chang-Yun Li; Dan Zhao; Guan-Jun Yang; Jiong Chen
Journal:  Front Oncol       Date:  2022-09-02       Impact factor: 5.738

7.  Monotropein Protects against Inflammatory Bone Loss and Suppresses Osteoclast Formation and Bone Resorption by Inhibiting NFATc1 via NF-κB and Akt/GSK-3β Pathway.

Authors:  Qi Zhang; Sijing Hu; Yuqiong He; Zile Song; Yi Shen; Zihui Zhao; Quanlong Zhang; Luping Qin; Qiaoyan Zhang
Journal:  Nutrients       Date:  2022-09-24       Impact factor: 6.706

Review 8.  Promising Antioxidative Effect of Berberine in Cardiovascular Diseases.

Authors:  Na An; Guoxia Zhang; Yingjian Li; Chao Yuan; Fan Yang; Lijing Zhang; Yonghong Gao; Yanwei Xing
Journal:  Front Pharmacol       Date:  2022-03-07       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.